MedPage Today - Latest Medical News/Health News Headlines
Latest Headlines News
-
FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
(MedPage Today) -- The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation associated with Alzheimer's disease dementia, the agency announced Thursday... -
Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps
(MedPage Today) -- The future of pulsed field ablation (PFA) technology could go in the direction of high-voltage nanosecond energy bursts, according to early results of a novel device.
With CellFX nsPFA-360 PFA for paroxysmal atrial fibrillation... -
Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders
(MedPage Today) -- Prenatal exposure to sedative drugs used for anxiety and insomnia was not associated with an increased risk of psychiatric or neurodevelopmental conditions in children when accounting for familial factors, a large population... -
As RFK Jr. Downplays Rabies, CDC Staff Tells Docs It's a Daily Threat
(MedPage Today) -- Just a week after Health Secretary Robert F. Kennedy Jr. downplayed rabies during a Senate hearing based on the few annual fatalities, CDC staff held a call with physicians to emphasize that preventing further deaths requires... -
Which Former NIH Official Was Indicted?
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz -
FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz
(MedPage Today) -- The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib.
In a "safe to proceed" letter to Revolution Medicines, the FDA gave its approval to initiate... -
Real-Time Trial Review Needs a Response Plan, Not Just a Data Feed
(MedPage Today) -- When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real time, FDA Commissioner Marty Makary, MD, MPH, reached for an analogy from his own training. As a surgical... -
First-in-Class Vepdegestrant Approved in Advanced Breast Cancer
(MedPage Today) -- The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced on Friday.
Approval of the first-in-class proteolysis targeting...